Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.58 |
| ▸ | LMNA | P02545 | 2/20 | 0.58 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.58 |
| ▸ | CNR1 | P21554 | 1/20 | 0.58 |
| ▸ | ATM | Q13315 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | FABP7 | O15540 | 1/20 | 0.44 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.44 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.43 |
| ▸ | ELANE | P08246 | 3/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.42 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6054965 | 0.90 | TDP1 (0.64) | TDP1L3MBTL1LMNAADRA2ACNR1 | |
| SCHEMBL3681483 | 0.87 | TDP1 (0.57) | TDP1L3MBTL1LMNAADRA2ACNR1 | |
| SCHEMBL3681480 | 0.87 | TDP1 (0.57) | TDP1L3MBTL1LMNAADRA2ACNR1 | |
| SCHEMBL1539179 | 0.86 | TDP1 (0.80) | TDP1L3MBTL1LMNAADRA2ACNR1 | |
| SCHEMBL1074161 | 0.86 | TDP1 (0.63) | TDP1L3MBTL1LMNAADRA2ACNR1 | |
| SCHEMBL1072275 | 0.86 | TDP1 (0.54) | TDP1L3MBTL1LMNAADRA2ACNR1 | |
| SCHEMBL1074157 | 0.86 | TDP1 (0.63) | TDP1L3MBTL1LMNAADRA2ACNR1 | |
| SCHEMBL22931582 | 0.86 | TDP1 (0.76) | TDP1L3MBTL1LMNAADRA2ACNR1 | |
| SCHEMBL523193 | 0.86 | TDP1 (0.76) | TDP1L3MBTL1LMNAADRA2ACNR1 | |
| SCHEMBL4433235 | 0.86 | TDP1 (0.76) | TDP1L3MBTL1LMNAADRA2ACNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2412702-B1 | METHOD FOR PRODUCING CYCLOPROPANECARBOXYLIC ACID ESTER | SUMITOMO CHEMICAL CO (JP) | 2014-12-03 | — | — | EP | disclosed |
| EP-1970369-B1 | METHOD FOR PRODUCING PURIFIED FORMYLCYCLOPROPANE COMPOUND AND INTERMEDIATE OF SUCH FORMYLCYCLOPROPANE COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2013-09-25 | — | — | EP | disclosed |
| US-8263797-B2 | Method for producing cyclopropane carboxylic acid compound and intermediate therefor | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-09-11 | — | — | US | disclosed |
| US-8168816-B2 | Method for producing purified formylcyclopropane compound and intermediate of such formylcyclopropane compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-05-01 | — | — | US | disclosed |
| EP-1535895-B1 | PROCESS FOR PRODUCTION OF FORMYLCYCLOPROPANECARBOXYLIC ESTERS | SUMITOMO CHEMICAL CO (JP) | 2012-04-25 | — | — | EP | disclosed |
| US-20120029227-A1 | METHOD FOR PRODUCING CYCLOPROPANECARBOXYLIC ACID ESTER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-02-02 | — | — | US | disclosed |
| EP-2412702-A1 | METHOD FOR PRODUCING CYCLOPROPANECARBOXYLIC ACID ESTER | Sumitomo Chemical Company, Limited (JP) | 2012-02-01 | — | — | EP | disclosed |
| EP-1609776-B1 | PROCESS FOR PRODUCTION OF CARBONYL COMPOUNDS | SUMITOMO CHEMICAL CO (JP) | 2011-03-02 | — | — | EP | disclosed |
| US-20100305353-A1 | METHOD FOR PRODUCING PURIFIED FORMYLCYCLOPROPANE COMPOUND AND INTERMEDIATE OF SUCH FORMYLCYCLOPROPANE COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-12-02 | — | — | US | disclosed |
| US-20100280267-A1 | METHOD FOR PRODUCING CYCLOPROPANE CARBOXYLIC ACID COMPOUND AND INTERMEDIATE THEREFOR | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-11-04 | — | — | US | disclosed |
| WO-2003066559-A1 | PROCESS FOR PRODUCTION OF ALDEHYDES AND KETONES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2003-08-14 | — | — | WO | disclosed |
| WO-2003066566-A1 | PROCESS FOR THE PRODUCTION OF TRANS-3,3-DIMETHYL-2-FORMLCYCLOPROPANE CARBOXYLIC ACID ESTERS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2003-08-14 | — | — | WO | disclosed |
| WO-2003059861-A1 | PROCESS FOR PRODUCTION OF 3,3-DIMETHYL-2-FORMYLCYCLOPROPANECARBOXYLIC ACID DERIVATIVES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2003-07-24 | — | — | WO | disclosed |
| US-6489505-B2 | REACTING CHRYSANTHEMIC ACID ESTER WITH HYDROGEN PEROXIDE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-12-03 | — | — | US | disclosed |
| EP-1188735-A1 | Process for producing carbonyl or hydroxy compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-03-20 | — | — | EP | disclosed |
| US-20020025906-A1 | Process for producing carbonyl or hydroxy compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-02-28 | — | — | US | disclosed |
| US-20020010361-A1 | Process for producing 3,3-dimethyl-2- formylcyclopropane-carboxylic acid ester | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-01-24 | — | — | US | disclosed |
| EP-1120393-A1 | A process for producing 3,3-dimethyl-2-formylcyclopropane-carboxylic acid ester | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-08-01 | — | — | EP | disclosed |
| US-4864052-A | 2,2-Dimethylcyclopropane-carboxylic acid derivatives | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1989-09-05 | — | — | US | disclosed |
| EP-0217342-A1 | 2,2-Dimethylcyclopropanecarboxylic acid derivatives | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1987-04-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120029227-A1 | METHOD FOR PRODUCING CYCLOPROPANECARBOXYLIC ACID ESTER | PCCA, COASY, GRHPR | TDP1 4158/4885L3MBTL1 4365/4885LMNA 1488/4885 |
| US-20100305353-A1 | METHOD FOR PRODUCING PURIFIED FORMYLCYCLOPROPANE COMPOUND AND INTERMEDIATE OF SUCH FORMYLCYCLOPROPANE COMPOUND | FPR1, FPR2, DHPS | TDP1 3608/4885L3MBTL1 4207/4885LMNA 4220/4885 |
| US-20100280267-A1 | METHOD FOR PRODUCING CYCLOPROPANE CARBOXYLIC ACID COMPOUND AND INTERMEDIATE THEREFOR | FAR1, CYP51A1, CYP4A11 | TDP1 3924/4885L3MBTL1 3363/4885LMNA 2745/4885 |
| US-20020010361-A1 | Process for producing 3,3-dimethyl-2- formylcyclopropane-carboxylic acid ester | ACSL6, ACSL3, TRMT1L | TDP1 3586/4885L3MBTL1 2566/4885LMNA 4764/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.